HIMS Relative Valuation
HIMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HIMS is overvalued; if below, it's undervalued.
Historical Valuation
Hims & Hers Health Inc (HIMS) is now in the Fair zone, suggesting that its current forward PS ratio of 4.74 is considered Fairly compared with the five-year average of -6.89. The fair price of Hims & Hers Health Inc (HIMS) is between 9.30 to 53.87 according to relative valuation methord.
Relative Value
Fair Zone
9.30-53.87
Current Price：48.62
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
20.51
P/B
Median3y
9.04
Median5y
5.16
2.22
FCF Yield
Median3y
0.97
Median5y
-0.94
Competitors Valuation Multiple
The average P/S ratio for HIMS's competitors is 1.82, providing a benchmark for relative valuation. Hims & Hers Health Inc Corp (HIMS) exhibits a P/S ratio of 4.56, which is 150.25% above the industry average. Given its robust revenue growth of 110.67%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Hims & Hers Health Inc (HIMS) currently overvalued or undervalued?
What is Hims & Hers Health Inc (HIMS) fair value?
How does HIMS's valuation metrics compare to the industry average?
What is the current P/B ratio for Hims & Hers Health Inc (HIMS) as of Jul 19 2025?
What is the current FCF Yield for Hims & Hers Health Inc (HIMS) as of Jul 19 2025?
What is the current Forward P/E ratio for Hims & Hers Health Inc (HIMS) as of Jul 19 2025?